Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 94 entries
View as:

Neoadjuvant CRT Combined With Camrelizumab and Nimotuzumab for Initially Inoperable Patients With Esophageal Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05355168 Org: User:
Start: 11/01/21 End: 03/31/24 Due: 03/31/25

Minimally Invasive Intracranial Hematoma Aspiration for Spontaneous Intracerebral Hemorrhage

Phase: N/A Priority: Normal
NCT ID: NCT06429553 Org: User:
Start: 07/01/23 End: 06/30/25 Due: 06/30/26

Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06602843 Org: User:
Start: 01/01/24 End: 12/31/26 Due: 12/31/27

Clinical Study of MRD Recurrence Monitoring After Surgical Resection of Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05458115 Org: User:
Start: 09/30/22 End: 12/31/24 Due: 12/31/25

"cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06590844 Org: User:
Start: 12/19/23 End: 03/31/26 Due: 03/31/27

Radiotherapy to All Residual Lesions After Chemoimmunotherapy

Phase: N/A Priority: Normal
NCT ID: NCT06479473 Org: User:
Start: 06/01/24 End: 03/31/26 Due: 03/31/27

A Study to Evaluate Tislelizumab Combined With Sitravatinib as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection

Phase: N/A Priority: Normal
NCT ID: NCT05407519 Org: User:
Start: 07/25/22 End: 06/30/26 Due: 06/30/27

The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT06362967 Org: User:
Start: 05/01/24 End: 06/30/27 Due: 06/30/28

A Clinical Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of MegaLT Injection for Treating Refractory Thrombocytopenia Following Radiotherapy, Chemotherapy, or Transplantation.

Phase: N/A Priority: Normal
NCT ID: NCT06534255 Org: User:
Start: 12/04/24 End: 12/31/26 Due: 12/31/27

Local Liver Treatment for Multi-organ Colorectal Cancer Metastases

Phase: N/A Priority: Normal
NCT ID: NCT06449937 Org: User:
Start: 07/31/24 End: 07/31/28 Due: 07/31/29

Pentoxifylline for the Prevention of PEP

Phase: N/A Priority: Normal
NCT ID: NCT02992678 Org: User:
Start: 12/31/16 End: 09/30/17 Due: 09/30/18

Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT05833594 Org: User:
Start: 07/01/23 End: 12/01/26 Due: 12/01/27

Comparison of Efficacy and Safety Between Ciprofol and Remimazolam During Fiberoptic Bronchoscopy

Phase: N/A Priority: Normal
NCT ID: NCT06531915 Org: User:
Start: 12/01/24 End: 03/31/25 Due: 03/31/26

Efficacy, Safety and Cost-effectiveness of PEG-rhG-CSF for Primary vs Secondary Prophylaxis

Phase: N/A Priority: Normal
NCT ID: NCT03701841 Org: User:
Start: 10/31/18 End: 12/31/20 Due: 12/31/21

Minimally Invasive Sweet Esophagectomy for Patients With Siewert Type II Adenocarcinoma of the Esophagogastric Junction

Phase: N/A Priority: Normal
NCT ID: NCT02741778 Org: User:
Start: 01/31/15 End: 12/31/17 Due: 12/31/18

Intravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06961669 Org: User:
Start: 04/16/25 End: 08/31/28 Due: 08/31/29

Avatrombopag for Platelet Recovery Post-UCBT in Patients With Bone Marrow Failure Disease

Phase: N/A Priority: Normal
NCT ID: NCT05823376 Org: User:
Start: 05/04/23 End: 02/28/25 Due: 02/28/26

Conducting Active Surveillance Without Prostate Biopsy for Patients With Low-risk Suspected Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05940415 Org: User:
Start: 10/08/23 End: 06/30/26 Due: 06/30/27

XELOX Combined With Apatinib as Post-operative Chemotherapy in Locally Advanced Gastric Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03599778 Org: User:
Start: 09/01/18 End: 01/30/25 Due: 01/30/26

China Liver Cancer Clinical Registry Cohort Database

Phase: N/A Priority: Normal
NCT ID: NCT06777485 Org: User:
Start: 01/01/25 End: 01/01/35 Due: 01/01/36

Ultrasensitive SERS Platform With Highly Efficient Enrichment of Analyte for Screening and Diagnosis of Epithelial Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06640348 Org: User:
Start: 01/01/25 End: 12/31/30 Due: 12/31/31

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

Phase: N/A Priority: Normal
NCT ID: NCT06498622 Org: User:
Start: 07/20/24 End: 05/20/27 Due: 05/20/28

Balloon Catheter vs. Basket Catheter for Endoscopic Bile Duct Stone Extraction

Phase: N/A Priority: Normal
NCT ID: NCT02909595 Org: User:
Start: 11/30/14 End: 11/30/16 Due: 11/30/17

The Treatment of High Intensity Transcranial Current Stimulation for Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT06380725 Org: User:
Start: 04/30/24 End: 12/31/24 Due: 12/31/25

The Addictive Diagnostic Value of Apparent Diffusion Coefficients to bpMRI in the Diagnosis of Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06737588 Org: User:
Start: 12/01/24 End: 03/31/27 Due: 03/31/28